Valneva SE
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-07 07:17 |
Regulatory News Service
Valneva annonce la levée de l’arrêt temporaire de la FDA sur l’utilisation du v…
|
French | 218.7 KB | |
| 2025-08-07 07:17 |
Regulatory News Service
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccin…
|
English | 222.5 KB | |
| 2025-07-11 17:35 |
Inside Information Statement
Valneva annonce la levée de la restriction temporaire de l'Agence européenne de…
|
French | 165.8 KB | |
| 2025-07-11 17:35 |
Inside Information Statement
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction …
|
English | 208.0 KB | |
| 2025-06-25 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 145.4 KB | |
| 2025-06-25 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY…
|
English | 119.4 KB | |
| 2025-06-05 17:45 |
Earnings Release
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance…
|
French | 236.5 KB | |
| 2025-06-05 17:45 |
Earnings Release
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Resu…
|
English | 178.3 KB | |
| 2025-06-05 07:30 |
Declaration of Voting Results & Voting Rights Announcements
[Valneva SE] Déclaration d’actions et de droits de vote - mai 2025
|
French | 160.2 KB | |
| 2025-06-05 07:30 |
Declaration of Voting Results & Voting Rights Announcements
[Valneva SE] Declaration of shares and voting rights - May 2025
|
English | 170.0 KB | |
| 2025-06-04 07:00 |
General Meeting Notice
Valneva annonce la mise à disposition des documents préparatoires à son Assembl…
|
French | 115.0 KB | |
| 2025-06-04 07:00 |
Regulatory News Service
Valneva Announces Availability of Documentation for its Combined Shareholder Me…
|
English | 122.8 KB | |
| 2025-05-26 17:30 |
Regulatory News Service
Valneva participera à différentes conférences d’investisseurs aux États-Unis et…
|
French | 150.8 KB | |
| 2025-05-26 17:30 |
Regulatory News Service
Valneva to Participate at U.S. and European Investor Conferences in June
|
English | 120.9 KB | |
| 2025-05-12 07:00 |
Regulatory News Service
Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les …
|
French | 163.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |